Jennifer Lynne Fox - Nov 11, 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Ext Aff, GC, Corp Sec
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Nov 11, 2022
Transactions value $
-$6,240
Form type
4
Date filed
11/15/2022, 03:13 PM
Previous filing
Mar 3, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$6.24K -416 -1.28% $15.00 32.2K Nov 11, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock of Emergent BioSolutions Inc withheld to pay tax liability on shares of restricted stock awarded pursuant to Rule 16b-3(d), which vested on November 11, 2022.